Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cigna Corp (CI) vs Rex Fang & Innovation Equity Premium Income ETF (FEPI) Price & Performance

Cigna CorpTrade
Rex Fang & Innovation Equity Premium Income ETFTrade

Price performance (Past 24H)

Key statistics

Cigna Corp vs Rex Fang & Innovation Equity Premium Income ETF — how do they compare? Cigna Corp trades at $273.79 (market cap $73.56B), while Rex Fang & Innovation Equity Premium Income ETF trades at $41.83. The key difference: Cigna Corp pays a 2.24% dividend while Rex Fang & Innovation Equity Premium Income ETF pays none, and Cigna Corp is trading nearer its 52-week high, Rex Fang & Innovation Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.

CIFEPI
Market Cap
$73.56B
Sector
HealthIncome / Options Overlay
52-Week High
$311.00$49.54
52-Week Low
$244.41$37.98
Enterprise Value
$98.27B
Dividend Yield
2.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cigna Corp

Cigna (CI) trades at $278.40, down 1.45% on the day, with a bearish technical signal but strong fundamentals including a P/E of 11.51 and ROE of 15.49%. Recent Q2 2026 earnings beat expectations at $7.78 per share, and the company raised its full-year EPS guidance. The stock is supported by consistent dividend payments and robust cash flow from operations of $9.60 billion in 2025.

The outlook is positive with a consensus price target of $338.90, implying 22% upside. Key opportunities include steady earnings growth and capital returns, while risks involve healthcare cost pressures and competitive dynamics. Analyst sentiment is strongly bullish with 73.68% buy ratings, though technical indicators suggest near-term caution.

Rex Fang & Innovation Equity Premium Income ETF

FEPI, the REX FANG & Innovation Equity Premium Income ETF, trades at $41.88, showing minimal daily movement with a 0.02% gain. The technical outlook is bullish based on moving averages, though oscillators are neutral. The ETF employs a covered call strategy on a concentrated basket of AI and mega-cap tech stocks, generating a high yield through weekly dividends, with recent payouts around $0.20-$0.21 per share. Recent news highlights its transition to weekly distributions and investor interest due to its aggressive income approach.

FEPI offers a high-yield opportunity through its covered call strategy, appealing for income-focused investors, but faces risks from NAV erosion in downturns and limited upside potential. The concentrated portfolio of volatile tech names increases exposure to sector-specific swings, requiring careful risk assessment for long-term holdings.

Returns comparison

Trailing returns across standard periods

About Cigna Corp

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.

Read more on CI

About Rex Fang & Innovation Equity Premium Income ETF

FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.

Read more on FEPI